Quilitz RE - Search Results

1

Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.

Brinda BJ, Pasikhova Y, Quilitz RE, Thai CM, Greene JN. Brinda BJ, et al. Among authors: quilitz re. J Hosp Infect. 2017 Apr;95(4):426-432. doi: 10.1016/j.jhin.2016.12.018. Epub 2016 Dec 29. J Hosp Infect. 2017. PMID: 28153556

2

Budget impact analysis of CYP2C19-guided voriconazole prophylaxis in AML.

Mason NT, Bell GC, Quilitz RE, Greene JN, McLeod HL. Mason NT, et al. Among authors: quilitz re. J Antimicrob Chemother. 2015 Nov;70(11):3124-6. doi: 10.1093/jac/dkv224. Epub 2015 Aug 1. J Antimicrob Chemother. 2015. PMID: 26233624 Free PMC article.

3

Infectious Risks and Complications in Adult Leukemic Patients Receiving Blinatumomab.

So W, Pandya S, Quilitz R, Shah B, Greene JN. So W, et al. Mediterr J Hematol Infect Dis. 2018 May 1;10(1):e2018029. doi: 10.4084/MJHID.2018.029. eCollection 2018. Mediterr J Hematol Infect Dis. 2018. PMID: 29755706 Free PMC article.

4

Mechanisms of high-level ceftolozane/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin.

So W, Shurko J, Galega R, Quilitz R, Greene JN, Lee GC. So W, et al. J Antimicrob Chemother. 2019 Jan 1;74(1):269-271. doi: 10.1093/jac/dky393. J Antimicrob Chemother. 2019. PMID: 30295837 No abstract available.

5

Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations.

Hicks JK, Quilitz RE, Komrokji RS, Kubal TE, Lancet JE, Pasikhova Y, Qin D, So W, Caceres G, Kelly K, Salchert YS, Shahbazian K, Abbas-Aghababazadeh F, Fridley BL, Velez AP, McLeod HL, Greene JN. Hicks JK, et al. Among authors: quilitz re. Clin Pharmacol Ther. 2020 Mar;107(3):563-570. doi: 10.1002/cpt.1641. Epub 2019 Nov 1. Clin Pharmacol Ther. 2020. PMID: 31549389 Free PMC article.

6

The Addition of Systemic Terbinafine to Antifungal Combination Therapy in the Treatment of Disseminated Drug-Resistant Mold Infections in a National Cancer Institute Comprehensive Cancer Center: A Six-Year Study.

Thomas DB Jr, Ajayi E, Sikora A, Cozzini L, Quilitz R, Pasikhova Y, Klinkova O, Baluch A. Thomas DB Jr, et al. Cureus. 2024 Mar 1;16(3):e55343. doi: 10.7759/cureus.55343. eCollection 2024 Mar. Cureus. 2024. PMID: 38559513 Free PMC article.

7

Dual antibiotic prevention bundle is associated with decreased surgical site infections.

Kuznicki M, Mallen A, McClung EC, Robertson SE, Todd S, Boulware D, Martin S, Quilitz R, Vargas RJ, Apte SM. Kuznicki M, et al. Int J Gynecol Cancer. 2020 Sep;30(9):1411-1417. doi: 10.1136/ijgc-2020-001515. Epub 2020 Jul 29. Int J Gynecol Cancer. 2020. PMID: 32727930 Free PMC article.

8

Thalidomide in Oncology: The Peril and the Promise.

Quilitz R. Quilitz R. Cancer Control. 1999 Oct;6(5):483-495. Cancer Control. 1999. PMID: 10758580 No abstract available.

9

Practice guidelines for lipid-based amphotericin B in stem cell transplant recipients.

Quilitz RE, Arnold AD, Briones GR, Dix SP, Ippoliti C, Kennedy LD, Lucich JL, Mehta J, Peters BG, Tice DS; H Lee Moffit Cancer Center, Tampa, FL. Quilitz RE, et al. Ann Pharmacother. 2001 Feb;35(2):206-16. doi: 10.1345/aph.10041. Ann Pharmacother. 2001. PMID: 11215842

10

The Use of Lipid Formulations of Amphotericin B in Cancer Patients.

Quilitz R. Quilitz R. Cancer Control. 1998 Oct;5(5):439-449. doi: 10.1177/107327489800500508. Cancer Control. 1998. PMID: 10761094 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters